TITLE

Review: Insulin monotherapy and insulin combined with oral hypoglycemic agents provide similar glycemic control: COMMENTARY

AUTHOR(S)
Kendall, David M.
PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article cites a medical study that examines two issues key to insulin use in the reviews of previous researchers. The review by these researchers concludes that no significant clinical advantage exists with the use of combination OHA-insulin therapy compared with insulin monotherapy. However, this result is not entirely unexpected because many of the trials used combination sulfonylurea-insulin therapy. These 2 insulin-providing treatments might not be expected to have substantial advantages over insulin injection alone.
ACCESSION #
17116521

 

Related Articles

  • Inhaled insulin added onto or replacing 2 oral agents reduced haemoglobin A1c concentrations in type 2 diabetes. Rosenstock, J. // Evidence Based Medicine;Jun2006, Vol. 11 Issue 3, p77 

    The article presents a study that examines whether inhaled insulin added onto two oral agents would reduce hemoglobin A1c concentrations in patients with type 2 diabetes. This study was observed in 309 patients with less 1 year history of type 2 diabetes treated with a stable oral agent regimen...

  • Pancreatic β-Cells Secrete Insulin in Fast- and Slow-Release Forms. Michael, Darren J.; Ritzel, Robert A.; Haataja, Leena; Chow, Robert H. // Diabetes;Mar2006, Vol. 55 Issue 3, p600 

    Insulin vesicles contain a chemically rich mixture of cargo that includes ions, small molecules, and proteins. At present, it is unclear if all components of this cargo escape from the vesicle at the same rate or to the same extent during exocytosis. Here, we demonstrate through real-time...

  • Adjunctive inhaled insulin before meals improved glycemic control more than adjunctive metformin in type 2 diabetes mellitus.  // ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p67 

    The article presents information on a study that finds effects of inhaling adjunctive insulin before meals. The study was conducted on 427 patients aging 35 to 80 years and having type 2 diabetes. The study reveals that adjunctive inhaled insulin are helpful in improving glycemic control more...

  • COMMENTARY: Adjunctive inhaled insulin before meals improved glycemic control more than adjunctive metformin in type 2 diabetes mellitus. Kudva, Yogish C.; Basu, Ananda // ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p67 

    The article presents the author's comments on a study that finds effects of inhaling adjunctive insulin before meals. The study reveals that adjunctive inhaled insulin are helpful in improving glycemic control more than adjunctive metformin in type 2 diabetes mellitus. In the author's opinion,...

  • Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs. Papa, G.; Fedele, V.; Chiavetta, A.; Lorenti, I.; Leotta, C.; Luca, S.; Rabuazzo, A. M.; Piro, S.; Alagona, C.; Spadaro, L.; Purrello, F.; Pezzino, V. // Acta Diabetologica;Mar2008, Vol. 45 Issue 1, p53 

    Glycemic control in elderly persons with type 2 diabetes mellitus (T2DM) is challenging because they are more likely to have other age-associated medical conditions and to experience hypoglycemia during intensive therapy. A best therapeutic strategy for these patients has not yet been defined....

  • Commentary. Murphy, Matthew; Dinneen, Sean // Evidence Based Medicine;Jun2006, Vol. 11 Issue 3, p77 

    The article comments on the medical research entitled "Inhaled Insulin Added Onto or Replacing Two Oral Agents Reduced Hemoglobin A1c concentrations in type 2 diabetes. The author cited that the design of the study, using comparator group without treatment intensification, overestimates inhaled...

  • Early Aggressive Therapy in Type 2 Diabetes Pays Off.  // Clinical Cardiology Alert;Aug2008 Primary Care Supplement, Vol. 13 Issue 8, p15 

    The article discusses research on early treatment against type 2 diabetes (DM2). It references a study by J. Weng et al published in a 2008 issue of the "Lancet." The clinical trial which involved patients with DM2 focused on the effectiveness of intensive insulin regimens (IIR) and oral...

  • Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus. Rajagopalan, Rukmini; Perez, Alfonso; Ye, Zhan; Khan, Mehmood; Murray, Frederick T. // Drugs & Aging;2004, Vol. 21 Issue 4, p259 

    Pioglitazone as monotherapy and in combination with sulfonylurea, metformin, or insulin has consistently demonstrated improved glycaemic and lipid parameters in patients with type 2 diabetes mellitus. Objective: We performed a subanalysis to examine the effect of pioglitazone on glycaemia and...

  • Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes. ESPOSITO, KATHERINE; PETRIZZO, MICHELA; CHIODINI, PAOLO; ROSARIA IMPROTA, MARIA; CAPUANO, ANNALISA; GIUGLIANO, DARIO // Diabetes Care;Dec2012, Vol. 35 Issue 12, p2698 

    OBJECTIVE-We compared the effect of insulin lispro protamine suspension (ILPS) with that of insulin glargine and insulin detemir, all given as basal supplementation, in the treatment of patients with type 2 diabetes. RESEARCH DESIGN AND METHODS-We conducted an electronic search until February...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics